Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• The Heme Catabolic Pathway and its Protective Effects on Oxidative Stress-Mediated DiseasesCyclooxygenase-2 and Tumor BiologyOligonucleotide Probes for RNA-Targeted Fluorescence In Situ HybridizationActivin A In Brain InjuryMethods for Predicting Human Drug MetabolismA Summary Analysis of Down Syndrome Markers in the Late First TrimesterEstrogen Hydroxylation in OsteoporosisCytochrome P450: Another Player in the Myocardial Infarction Game?Index

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• The Heme Catabolic Pathway and its Protective Effects on Oxidative Stress-Mediated DiseasesCyclooxygenase-2 and Tumor BiologyOligonucleotide Probes for RNA-Targeted Fluorescence In Situ HybridizationActivin A In Brain InjuryMethods for Predicting Human Drug MetabolismA Summary Analysis of Down Syndrome Markers in the Late First TrimesterEstrogen Hydroxylation in OsteoporosisCytochrome P450: Another Player in the Myocardial Infarction Game?Index

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• The Heme Catabolic Pathway and its Protective Effects on Oxidative Stress-Mediated DiseasesCyclooxygenase-2 and Tumor BiologyOligonucleotide Probes for RNA-Targeted Fluorescence In Situ HybridizationActivin A In Brain InjuryMethods for Predicting Human Drug MetabolismA Summary Analysis of Down Syndrome Markers in the Late First TrimesterEstrogen Hydroxylation in OsteoporosisCytochrome P450: Another Player in the Myocardial Infarction Game?Index